We speculate that insufficiency of this anti-aging protein may have a role in the pathogenesis of CAVD, an aging-related valvular heart disease, and that recombinant Klotho may have therapeutic potential to prevent CAVD progression. The gene discussed is KL; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.